Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4008 | 1790 | 36.5 | 63% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FACTOR XII | Author keyword | 135 | 63% | 8% | 135 |
2 | FACTOR XI | Author keyword | 123 | 68% | 6% | 109 |
3 | FACTOR XI DEFICIENCY | Author keyword | 108 | 74% | 5% | 81 |
4 | PREKALLIKREIN | Author keyword | 67 | 68% | 3% | 58 |
5 | HIGH MOLECULAR WEIGHT KININOGEN | Author keyword | 55 | 63% | 3% | 55 |
6 | SOL SHERRY THROMBOSIS | Address | 34 | 27% | 6% | 106 |
7 | KININOGEN | Author keyword | 34 | 34% | 5% | 81 |
8 | PREKALLIKREIN DEFICIENCY | Author keyword | 23 | 100% | 1% | 10 |
9 | FXI DEFICIENCY | Author keyword | 21 | 85% | 1% | 11 |
10 | FACTOR XII DEFICIENCY | Author keyword | 17 | 62% | 1% | 18 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FACTOR XII | 135 | 63% | 8% | 135 | Search FACTOR+XII | Search FACTOR+XII |
2 | FACTOR XI | 123 | 68% | 6% | 109 | Search FACTOR+XI | Search FACTOR+XI |
3 | FACTOR XI DEFICIENCY | 108 | 74% | 5% | 81 | Search FACTOR+XI+DEFICIENCY | Search FACTOR+XI+DEFICIENCY |
4 | PREKALLIKREIN | 67 | 68% | 3% | 58 | Search PREKALLIKREIN | Search PREKALLIKREIN |
5 | HIGH MOLECULAR WEIGHT KININOGEN | 55 | 63% | 3% | 55 | Search HIGH+MOLECULAR+WEIGHT+KININOGEN | Search HIGH+MOLECULAR+WEIGHT+KININOGEN |
6 | KININOGEN | 34 | 34% | 5% | 81 | Search KININOGEN | Search KININOGEN |
7 | PREKALLIKREIN DEFICIENCY | 23 | 100% | 1% | 10 | Search PREKALLIKREIN+DEFICIENCY | Search PREKALLIKREIN+DEFICIENCY |
8 | FXI DEFICIENCY | 21 | 85% | 1% | 11 | Search FXI+DEFICIENCY | Search FXI+DEFICIENCY |
9 | FACTOR XII DEFICIENCY | 17 | 62% | 1% | 18 | Search FACTOR+XII+DEFICIENCY | Search FACTOR+XII+DEFICIENCY |
10 | CONTACT ACTIVATION | 17 | 40% | 2% | 34 | Search CONTACT+ACTIVATION | Search CONTACT+ACTIVATION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOLECULAR WEIGHT KININOGEN | 154 | 41% | 16% | 292 |
2 | COAGULATION FACTOR XI | 129 | 72% | 6% | 100 |
3 | COAGULATION FACTOR XII | 127 | 63% | 7% | 129 |
4 | HAGEMAN FACTOR | 117 | 46% | 11% | 191 |
5 | PREKALLIKREIN | 117 | 55% | 8% | 146 |
6 | CONTACT ACTIVATION | 81 | 51% | 6% | 113 |
7 | HUMAN HAGEMAN FACTOR | 66 | 69% | 3% | 57 |
8 | APPLE 3 DOMAIN | 52 | 100% | 1% | 18 |
9 | CONTACT SYSTEM | 49 | 43% | 5% | 88 |
10 | PLASMA THROMBOPLASTIN ANTECEDENT | 48 | 68% | 2% | 42 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Contact system: A vascular biology modulator with anticoagulant, Profibrinolytic, antiadhesive, and proinflammatory attributes | 1997 | 305 | 230 | 71% |
Pathways for bradykinin formation and inflammatory disease | 2002 | 155 | 108 | 58% |
Structure and function of factor XI | 2010 | 35 | 96 | 79% |
The procoagulant and proinflammatory plasma contact system | 2012 | 31 | 68 | 51% |
Factor XII: What does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis | 2010 | 30 | 57 | 79% |
Formation of bradykinin: A major contributor to the innate inflammatory response | 2005 | 75 | 176 | 73% |
Pathogenic Mechanisms of Bradykinin Mediated Diseases: Dysregulation of an Innate Inflammatory Pathway | 2014 | 7 | 146 | 57% |
The intrinsic pathway of coagulation: a target for treating thromboembolic disease? | 2007 | 84 | 56 | 63% |
Intrinsic pathway of coagulation and arterial thrombosis | 2007 | 106 | 71 | 49% |
Factor XI as a target for antithrombotic therapy | 2014 | 3 | 36 | 86% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SOL SHERRY THROMBOSIS | 34 | 27% | 5.9% | 106 |
2 | KENT HAEMOPHILIA | 6 | 42% | 0.6% | 11 |
3 | AMALIA BIRON THROMBOSIS HEMOSTASIS | 5 | 25% | 0.9% | 17 |
4 | PULM CRIT CARE ASTHMA ALLERGY | 4 | 75% | 0.2% | 3 |
5 | KONISHI MUSC INFLAMMAT | 4 | 46% | 0.3% | 6 |
6 | HEART CIRCULATORY SECT | 2 | 67% | 0.1% | 2 |
7 | KAROLINSKA UNIV HOSP SOLNA L1 00 | 2 | 67% | 0.1% | 2 |
8 | CHEM UTILIZAT ANIM OURCES | 2 | 50% | 0.2% | 3 |
9 | GROWTH REPROD MED | 2 | 43% | 0.2% | 3 |
10 | PULM CRIT CARE ALLERGY CLIN IMMUNOL | 1 | 25% | 0.3% | 5 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000191532 | PROLYLCARBOXYPEPTIDASE//PRCP//ANGIOTENSINASE C |
2 | 0.0000188122 | T KININOGEN//T KININ//M 5011 |
3 | 0.0000093961 | HEREDITARY ANGIOEDEMA//C1 INHIBITOR//ANGIOEDEMA |
4 | 0.0000093181 | THROMBIN GENERATION//SYN SE BV//PHYS BIOCHEM BLOOD |
5 | 0.0000091162 | PEAT ENERGY//ELECTRODE ADSORPTION//LECMA |
6 | 0.0000084772 | FSAP//FACTOR VII ACTIVATING PROTEASE//PLASMA HYALURONAN BINDING PROTEIN |
7 | 0.0000073075 | HISTIDINE RICH GLYCOPROTEIN//HRG//HISTIDINE PROLINE RICH GLYCOPROTEIN |
8 | 0.0000063374 | FACTOR VII DEFICIENCY//FACTOR X DEFICIENCY//FACTOR VII |
9 | 0.0000054177 | BRADYKININ//B 1 RECEPTOR//BRADYKININ B 1 RECEPTOR |
10 | 0.0000047945 | FACTOR V DEFICIENCY//FACTOR VA//FACTOR V |